{"id":1596625,"date":"2021-07-01T13:16:01","date_gmt":"2021-07-01T10:16:01","guid":{"rendered":"https:\/\/www.enikos.gr\/uncategorized\/emvolia-astrazeneca-moderna-kai-pfizer-afti-einai-i-apotelesmatik\/1596625\/"},"modified":"2021-07-01T13:16:01","modified_gmt":"2021-07-01T10:16:01","slug":"emvolia-astrazeneca-moderna-kai-pfizer-afti-einai-i-apotelesmatik","status":"publish","type":"post","link":"https:\/\/www.enikos.gr\/society\/emvolia-astrazeneca-moderna-kai-pfizer-afti-einai-i-apotelesmatik\/1596625\/","title":{"rendered":"\u0395\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 AstraZeneca, Moderna \u03ba\u03b1\u03b9 Pfizer: \u0391\u03c5\u03c4\u03ae \u03b5\u03af\u03bd\u03b1\u03b9 \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03ac \u03c4\u03bf\u03c5\u03c2 \u03b1\u03c0\u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c3\u03c4\u03b7 \u03bc\u03b5\u03c4\u03ac\u03bb\u03bb\u03b1\u03be\u03b7 \u0394\u03ad\u03bb\u03c4\u03b1"},"content":{"rendered":"<p>\u03a4\u03b1 \u03b5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03b1 <a href=\"https:\/\/www.enikos.gr\/society\/784017\/koronoios-poso-apotelesmatika-einai-ta-emvolia-apenanti-sta-metal\">\u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 <\/a>\u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03bf\u03c5 \u03b9\u03bf\u03cd \u03ba\u03bf\u03c1\u03bf\u03bd\u03bf\u03ca\u03bf\u03cd \u03ad\u03c7\u03bf\u03c5\u03bd \u03b1\u03c0\u03bf\u03b4\u03b5\u03b9\u03c7\u03b8\u03b5\u03af \u03c0\u03bf\u03bb\u03cd <a href=\"https:\/\/www.enikos.gr\/society\/781006\/koronoios-nea-meleti-gia-tin-apotelesmatikotita-kai-tin-asfaleia-\">\u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac <\/a>\u03c3\u03c4\u03bf\u03bd \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c4\u03b7\u03c2 \u03c0\u03b1\u03bd\u03b4\u03b7\u03bc\u03af\u03b1\u03c2, \u03b1\u03bb\u03bb\u03ac \u03ad\u03c7\u03bf\u03c5\u03bd \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03c3\u03c4\u03b9\u03c2 \u03b1\u03c1\u03c7\u03ad\u03c2 \u03c4\u03b7\u03c2 \u03c0\u03b1\u03bd\u03b4\u03b7\u03bc\u03af\u03b1\u03c2 \u03c0\u03c1\u03b9\u03bd \u03b5\u03bc\u03c6\u03b1\u03bd\u03b9\u03c3\u03c4\u03bf\u03cd\u03bd \u03c4\u03b1 \u03bd\u03b5\u03cc\u03c4\u03b5\u03c1\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7. \u039a\u03ac\u03c0\u03bf\u03b9\u03b1 \u03b1\u03c0\u03cc \u03c4\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7 \u03b1\u03c5\u03c4\u03ac \u03ad\u03c7\u03bf\u03c5\u03bd \u03c4\u03b7 \u03b4\u03c5\u03bd\u03b1\u03c4\u03cc\u03c4\u03b7\u03c4\u03b1 \u03bd\u03b1 \u03be\u03b5\u03c0\u03b5\u03c1\u03bd\u03bf\u03cd\u03bd \u03c4\u03b7\u03bd \u03b1\u03bd\u03bf\u03c3\u03af\u03b1 \u03c0\u03bf\u03c5 \u03c0\u03b1\u03c1\u03ad\u03c7\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1. \u039f\u03b9 \u0399\u03b1\u03c4\u03c1\u03bf\u03af \u03c4\u03b7\u03c2 \u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae\u03c2 \u03c4\u03b7\u03c2 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u03a3\u03c7\u03bf\u03bb\u03ae\u03c2 \u03c4\u03bf\u03c5 \u0395\u03b8\u03bd\u03b9\u03ba\u03bf\u03cd \u03ba\u03b1\u03b9 \u039a\u03b1\u03c0\u03bf\u03b4\u03b9\u03c3\u03c4\u03c1\u03b9\u03b1\u03ba\u03bf\u03cd \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, <b>\u0398\u03b5\u03bf\u03b4\u03ce\u03c1\u03b1 \u03a8\u03b1\u03bb\u03c4\u03bf\u03c0\u03bf\u03cd\u03bb\u03bf\u03c5<\/b>, <b>\u03a0\u03ac\u03bd\u03bf\u03c2 \u039c\u03b1\u03bb\u03b1\u03bd\u03b4\u03c1\u03ac\u03ba\u03b7\u03c2<\/b>, <b>\u0393\u03b9\u03ac\u03bd\u03bd\u03b7\u03c2 \u039d\u03c4\u03ac\u03bd\u03b1\u03c3\u03b7\u03c2<\/b> \u03ba\u03b1\u03b9 <b>\u0398\u03ac\u03bd\u03bf\u03c2 \u0394\u03b7\u03bc\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2<\/b> (\u03a0\u03c1\u03cd\u03c4\u03b1\u03bd\u03b7\u03c2 \u0395\u039a\u03a0\u0391) \u03c3\u03c5\u03bd\u03bf\u03c8\u03af\u03b6\u03bf\u03c5\u03bd \u03c4\u03b1 \u03bd\u03b5\u03cc\u03c4\u03b5\u03c1\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1. <\/p>\n<p>\u03a3\u03b5 \u03bc\u03b9\u03b1 \u03c0\u03c1\u03cc\u03c3\u03c6\u03b1\u03c4\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c0\u03bf\u03c5 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c4\u03b7\u03ba\u03b5 \u03c3\u03c4\u03bf \u03b4\u03b9\u03b5\u03b8\u03bd\u03ad\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03cc Lancet (E.C.Wall \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03ac\u03c4\u03b5\u03c2, AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC, DOI:https:\/\/doi.org\/10.1016\/S0140-6736(21)01462-8) \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1\u03c2 AstraZeneca \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c3\u03c4\u03bf \u03bd\u03ad\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u03c4\u03bf\u03c5 SARS-CoV-2 \u0394\u03ad\u03bb\u03c4\u03b1.<\/p>\n<p> \u038c\u03c3\u03bf\u03bd \u03b1\u03c6\u03bf\u03c1\u03ac \u03c3\u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ce\u03bd \u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03ac\u03c4\u03c9\u03bd \u03bc\u03b5\u03c4\u03ac \u03c4\u03bf\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 <b>\u03b4\u03cd\u03bf<\/b> <b>\u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 <\/b><b>ASTRA <\/b><b>ZENECA (<\/b><b>AZD1222), \u03c3\u03c7\u03b5\u03b4\u03cc\u03bd \u03cc\u03bb\u03bf\u03b9 \u03bf\u03b9 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 (55\/63, 87%) \u03b5\u03af\u03c7\u03b1\u03bd \u03b1\u03bd\u03b9\u03c7\u03bd\u03b5\u03cd\u03c3\u03b9\u03bc\u03b1 \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ac \u03b1\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03c9\u03bd \u03c3\u03c4\u03b5\u03bb\u03b5\u03c7\u03ce\u03bd <\/b><b>D614<\/b><b>G  (\u03b1\u03c1\u03c7\u03b9\u03ba\u03cc \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2) \u03ba\u03b1\u03b9 \u0392.1.1.7 (\u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u03ac\u03bb\u03c6\u03b1, \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf)<\/b>, \u03b5\u03bd\u03ce \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf\u03b9 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03b9 \u03b5\u03af\u03c7\u03b1\u03bd \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ac \u03b1\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 <b>\u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03bf\u03c5 \u0392.1.351 (\u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u03b2\u03ae\u03c4\u03b1, \u039d\u03cc\u03c4\u03b9\u03b1 \u0391\u03c6\u03c1\u03b9\u03ba\u03ae) (38\/63, 60%) \u03ba\u03b1\u03b9 \u03c4\u03bf\u03c5 \u0392.1.617.2 (\u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u03b4\u03ad\u03bb\u03c4\u03b1, \u0399\u03bd\u03b4\u03af\u03b1) (39\/63, 62%)<\/b>. \u0391\u03bd\u03c4\u03af\u03b8\u03b5\u03c4\u03b1, <b>\u03ac\u03bd\u03c9 \u03c4\u03bf\u03c5 95% \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03bc\u03b5 \u03c4\u03b9\u03c2 \u03b4\u03cd\u03bf \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 <\/b><b>Pfizer (<\/b><b>BNT162<\/b><b>b2) \u03b1\u03bd\u03ad\u03c0\u03c4\u03c5\u03be\u03b1\u03bd \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ac \u03b1\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03c9\u03bd \u03c3\u03c4\u03b5\u03bb\u03b5\u03c7\u03ce\u03bd \u0392.1.351 \u03ba\u03b1\u03b9 \u0392.1.617.2.<\/b> \u0388\u03bd\u03b1 \u03ac\u03bb\u03bb\u03bf \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc \u03b5\u03cd\u03c1\u03b7\u03bc\u03b1 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2 \u03ad\u03b3\u03ba\u03b5\u03b9\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u03cc\u03c4\u03b9 \u03bf\u03b9 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 \u03bc\u03b5 <b>\u03c0\u03c1\u03bf\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03bb\u03bf\u03af\u03bc\u03c9\u03be\u03b7 <\/b><b>COVID-19 \u03b5\u03af\u03c7\u03b1\u03bd \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03b1 \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ac \u03b1\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c3\u03b5 \u03cc\u03bb\u03b1 \u03c4\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7<\/b> \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc \u03bc\u03af\u03b1 \u03bc\u03cc\u03bd\u03bf \u03b4\u03cc\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 ASTRA ZENECA (AZD1222) \u03c3\u03c5\u03b3\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03cc\u03c3\u03bf\u03c5\u03c2 \u03b4\u03b5\u03bd \u03b5\u03af\u03c7\u03b1\u03bd \u03bd\u03bf\u03c3\u03ae\u03c3\u03b5\u03b9. \u03a3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b1\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac, \u03bf\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2 \u03c3\u03b7\u03bc\u03b5\u03b9\u03ce\u03bd\u03bf\u03c5\u03bd \u03cc\u03c4\u03b9 \u03bf\u03b9 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03b8\u03ad\u03bd\u03c4\u03b5\u03c2 \u03bc\u03b5 \u03c4\u03bf ASTRA ZENECA \u03ad\u03c7\u03bf\u03c5\u03bd \u03c5\u03c0\u03bf\u03b4\u03b5\u03ad\u03c3\u03c4\u03b5\u03c1\u03b7 \u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03b1\u03c0\u03ac\u03bd\u03c4\u03b7\u03c3\u03b7 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03bf\u03c5 SARS-CoV-2 \u03c3\u03c5\u03b3\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03bf Pfizer, \u03c4\u03bf \u03bf\u03c0\u03bf\u03af\u03bf \u03c3\u03c5\u03bd\u03ac\u03b4\u03b5\u03b9 \u03c4\u03cc\u03c3\u03bf \u03bc\u03b5 \u03c4\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03c4\u03c9\u03bd \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ce\u03bd \u03bc\u03b5\u03bb\u03b5\u03c4\u03ce\u03bd \u03cc\u03c3\u03bf \u03ba\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03b1 \u03c0\u03c1\u03bf\u03c3\u03c6\u03ac\u03c4\u03c9\u03c2 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03c5\u03bc\u03ad\u03bd\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03b1\u03c0\u03cc \u03c4\u03bf \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03b5\u03bd\u03ac\u03bd\u03c4\u03b9\u03b1 \u03c3\u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 B.1.617.2 (60% ASTRA ZENECA \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 79% BNT162b2) \u03ba\u03b1\u03b9 \u03c3\u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0392.1.1.7 (73% AZD1222 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 92% Pfizer) (Lancet. 2021; 397: 2461-2462; MedRxiv https:\/\/doi.org\/10.1101\/2021.05.22.21257658).<\/p>\n<p>\u039c\u03b9\u03b1 \u03ac\u03bb\u03bb\u03b7 \u03c0\u03c1\u03cc\u03c3\u03c6\u03b1\u03c4\u03b7 \u03c0\u03c1\u03bf\u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b7 \u03c4\u03c9\u03bd A.Choi \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03b1\u03c4\u03ce\u03bd (<a href=\"https:\/\/www.biorxiv.org\/content\/10.1101\/2021.06.28.449914v1\" rel=\"noopener\">https:\/\/www.biorxiv.org\/content\/10.1101\/2021.06.28.449914v1<\/a>) \u03b1\u03bd\u03ad\u03bb\u03c5\u03c3\u03b5 \u03c4\u03b7\u03bd \u03b9\u03ba\u03b1\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03ad\u03c1\u03c9\u03c3\u03b7\u03c2 \u03c3\u03c4\u03b5\u03bb\u03b5\u03c7\u03ce\u03bd \u03c4\u03bf\u03c5 SARS-CoV-2. \u039f\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2 \u03c3\u03c5\u03bb\u03bb\u03ad\u03be\u03b1\u03bd\u03b5 \u03bf\u03c1\u03bf\u03cd\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03c9\u03bd \u03bc\u03b5 \u03b4\u03cd\u03bf \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 Moderna \u03bc\u03af\u03b1 \u03b5\u03b2\u03b4\u03bf\u03bc\u03ac\u03b4\u03b1 \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7 \u03b4\u03cc\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03ad\u03bb\u03b5\u03b3\u03be\u03b1\u03bd \u03c4\u03b7\u03bd \u03b9\u03ba\u03b1\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03ad\u03c1\u03c9\u03c3\u03b7\u03c2 \u03c3\u03c4\u03bf \u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf. <b>\u039f \u03c0\u03bb\u03ae\u03c1\u03b7\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc\u03c2 \u03bf\u03b4\u03ae\u03b3\u03b7\u03c3\u03b5 \u03c3\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03b5\u03be\u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03c9\u03c4\u03b9\u03ba\u03ce\u03bd \u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03ac\u03c4\u03c9\u03bd \u03b1\u03c0\u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c3\u03b5 \u03cc\u03bb\u03b1 \u03c4\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7, \u03cc\u03c0\u03c9\u03c2 \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0392\u03ae\u03c4\u03b1 (<\/b><b>B.1.351, \u039d\u03cc\u03c4\u03b9\u03b1\u03c2 \u0391\u03c6\u03c1\u03b9\u03ba\u03ae\u03c2), \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0392.1.617 (\u0399\u03bd\u03b4\u03af\u03b1\u03c2), \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u039a\u03ac\u03c0\u03c0\u03b1 (\u0392.1.617.1), \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0394\u03ad\u03bb\u03c4\u03b1 (\u0392.1.617.2), \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0397\u03c4\u03b1 (\u0392.1.525, \u039d\u03b9\u03b3\u03b7\u03c1\u03af\u03b1\u03c2), \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0391.23.1 (\u039f\u03c5\u03b3\u03ba\u03ac\u03bd\u03c4\u03b1) \u03ba\u03b1\u03b9 \u03c4\u03bf \u03c3\u03c4\u03ad\u03bb\u03b5\u03c7\u03bf\u03c2 \u0391.<\/b><b>VOI.<\/b><b>V2 (\u0391\u03b3\u03ba\u03cc\u03bb\u03b1).<\/b><\/p>\n<p>\u03a3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b1\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac, \u03c4\u03b1 \u03b1\u03bd\u03c9\u03c4\u03ad\u03c1\u03c9 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03b4\u03b5\u03af\u03c7\u03bd\u03bf\u03c5\u03bd \u03cc\u03c4\u03b9 \u03b1\u03c6\u03b5\u03bd\u03cc\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc \u03bd\u03b1 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03c4\u03bf \u03c0\u03bb\u03ae\u03c1\u03b5\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc \u03c0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03ba\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03b9\u03c2 \u03b4\u03cd\u03bf \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd AstraZeneca, Pfizer \u03ba\u03b1\u03b9 Moderna \u03ba\u03b1\u03b8\u03ce\u03c2 \u03c0\u03c1\u03bf\u03c3\u03c6\u03ad\u03c1\u03bf\u03c5\u03bd \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03b5\u03bd\u03ac\u03bd\u03c4\u03b9\u03b1 \u03ba\u03b1\u03b9 \u03c3\u03c4\u03b1 \u03bd\u03b5\u03cc\u03c4\u03b5\u03c1\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7 \u03c4\u03bf\u03c5 SARS-CoV-2. \u039c\u03ad\u03c7\u03c1\u03b9 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1, \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1 \u03c0\u03b5\u03c1\u03af\u03c0\u03bf\u03c5 \u03c4\u03bf 50% \u03c4\u03c9\u03bd \u0395\u03bb\u03bb\u03ae\u03bd\u03c9\u03bd \u03ad\u03c7\u03b5\u03b9 \u03bb\u03ac\u03b2\u03b5\u03b9 \u03c4\u03bf\u03c5\u03bb\u03ac\u03c7\u03b9\u03c3\u03c4\u03bf\u03bd \u03c4\u03b7\u03bd 1\u03b7 \u03b4\u03cc\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03c3\u03c4\u03bf 36% \u03bf \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc\u03c2 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af. \u0391\u03c6\u03b5\u03c4\u03ad\u03c1\u03bf\u03c5 \u03b1\u03be\u03af\u03b6\u03b5\u03b9 \u03bd\u03b1 \u03b1\u03be\u03b9\u03bf\u03bb\u03bf\u03b3\u03b7\u03b8\u03b5\u03af \u03b7 \u03c0\u03b9\u03b8\u03b1\u03bd\u03ae \u03c7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7 \u03b1\u03bd\u03b1\u03bc\u03bd\u03b7\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03b4\u03cc\u03c3\u03b5\u03c9\u03bd \u03b5\u03b9\u03b4\u03b9\u03ba\u03ac \u03b3\u03b9\u03b1 \u03cc\u03c3\u03bf\u03c5\u03c2 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c7\u03b1\u03bc\u03b7\u03bb\u03ae \u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03b1\u03c0\u03ac\u03bd\u03c4\u03b7\u03c3\u03b7.<\/p>\n<p style=\"text-align: justify\">\n","protected":false},"excerpt":{"rendered":"<p>\u03a4\u03b1 \u03b5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03bf\u03c5 \u03b9\u03bf\u03cd \u03ba\u03bf\u03c1\u03bf\u03bd\u03bf\u03ca\u03bf\u03cd \u03ad\u03c7\u03bf\u03c5\u03bd \u03b1\u03c0\u03bf\u03b4\u03b5\u03b9\u03c7\u03b8\u03b5\u03af \u03c0\u03bf\u03bb\u03cd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03c3\u03c4\u03bf\u03bd \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c4\u03b7\u03c2 \u03c0\u03b1\u03bd\u03b4\u03b7\u03bc\u03af\u03b1\u03c2, \u03b1\u03bb\u03bb\u03ac \u03ad\u03c7\u03bf\u03c5\u03bd \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03c3\u03c4\u03b9\u03c2 \u03b1\u03c1\u03c7\u03ad\u03c2 \u03c4\u03b7\u03c2 \u03c0\u03b1\u03bd\u03b4\u03b7\u03bc\u03af\u03b1\u03c2 \u03c0\u03c1\u03b9\u03bd \u03b5\u03bc\u03c6\u03b1\u03bd\u03b9\u03c3\u03c4\u03bf\u03cd\u03bd \u03c4\u03b1 \u03bd\u03b5\u03cc\u03c4\u03b5\u03c1\u03b1 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03b7&#8230;<\/p>\n","protected":false},"author":26,"featured_media":1596626,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[6],"tags":[180797,191942,189140,8621,26754,20525,67225,180124],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/posts\/1596625"}],"collection":[{"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/comments?post=1596625"}],"version-history":[{"count":0,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/posts\/1596625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/media\/1596626"}],"wp:attachment":[{"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/media?parent=1596625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/categories?post=1596625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enikos.gr\/v2\/wp\/v2\/tags?post=1596625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}